| |
|
|
|
Oxford Global, Novotel London West, London, UK
20-21 April 2015
To view the agenda in full, please visit http://www.biosimilars-congress.com/download-agenda-marketing/
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
- Mehrshid Alai-Safar
Senior Director Regulatory Affairs, Baxter - Ayse Baker
Director, Lixisenatide Family Projects – Diabetes, Sanofi - Chetak Buaria
Director – Alliance Management (Biosimilars), Merck Serono - Matthew Cooper
Life Sciences Development Director, NHS - Rakesh Dixit
Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune - Uwe Gudat
Head of Safety, Biosimilars, Merck Serono - Ira Jacobs
Oncology Portfolio Global Medical Lead – Biosimilars, Pfizer - Takashi Kei Kishimoto
Chief Scientific Officer, Selecta Biosciences - Hootan Khatami
Senior Medical Director, Global Medical Affairs, Sanofi - Emmanuelle Lepine
Vice President of Business Development, Alvotech - Patrick Liu
Senior Director and Global Head of Bioassays, Teva - Malcolm Mitchell
Senior Medical Fellow, Clinical Pharmacology, Eli Lilly - Julie O’Brien
Senior Manager, Emerging Markets Regulatory Policy, Pfizer - Laurent Rebier
Director, Business Development, Merck Serono - Alexandre Richard
Director – Business Intelligence, Sanofi - Joey Studts
Director Purification and Formulation Science, Boehringer Ingelheim - Benita von Glahn
Head of Regulatory Affairs, Biosimilars, Boehringer Ingelheim
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
For further information on the Congress, or to enquire about available discounts and to register, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk or call +44 (0)1865 248455.
|
|
|
E-mail:
|
|
s.punfield@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|